Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Attig

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Cell Reports|December 3, 2013
Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxicYoun-Bok Lee, Han-Jou Chen, João N Peres, et al.
Blood Neoplasia|August 1, 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemiaMartin Hutchings, Koorosh Korfi, Pau Montesinos, et al.
Blood|October 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myelomaJan Eckmann, Tanja Fauti, Marlene Biehl, et al.
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Cancer Cell|October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinomaLewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Cell Reports|December 3, 2013
Hexanucleotide repeats in ALS/FTD form length-dependent RNA foci, sequester RNA binding proteins, and are neurotoxicYoun-Bok Lee, Han-Jou Chen, João N Peres, et al.
Blood Neoplasia|August 1, 2025
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemiaMartin Hutchings, Koorosh Korfi, Pau Montesinos, et al.
Blood|October 30, 2024
Forimtamig, a novel GPRC5D-targeting T-cell bispecific antibody with a 2+1 format, for the treatment of multiple myelomaJan Eckmann, Tanja Fauti, Marlene Biehl, et al.
Nature|January 14, 2026
Retraction Note: Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Nature|April 12, 2023
Antibodies against endogenous retroviruses promote lung cancer immunotherapyKevin W Ng, Jesse Boumelha, Katey S S Enfield, et al.
Cancer Cell|October 29, 2021
Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinomaLewis Au, Emine Hatipoglu, Marc Robert de Massy, et al.
Pageof 4